Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rani Soenen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Dermatological Treatment|October 6, 2020
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured surveyLisa Schots, Lynda Grine, Rani Soenen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 23, 2022
Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohortLisa Schots, Rani Soenen, Brigitte Blanquart, et al.
Dermatology and Therapy|October 4, 2024
Demographics, Disease Characteristics, and Time to Effective Treatment of Patients with Psoriasis in the Ghent PsoPlus Cohort of 2021Evelyn Meulewaeter, Anke Eylenbosch, Evelien Verhaeghe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2025
From reactive to predictive: Advancing biologic dosing in dermatologyAnke Eylenbosch, Ruoheng Wei, Rani Soenen, et al.
Clinical and Experimental Dermatology|March 4, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasisRani Soenen, Zhigang Wang, Lynda Grine, et al.
Journal of Clinical Medicine|June 10, 2022
Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical PracticeRani Soenen, Christophe Stove, Alessio Capobianco, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2020
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasisNathalie Van den Berghe, Aurélie Truffot, Miet Peeters, et al.
The Journal of Investigative Dermatology|July 8, 2026
Population Pharmacokinetic-Pharmacodynamic Model for Secukinumab in Psoriasis PatientsAnke Eylenbosch, Rani Soenen, Charlotte A M van Riel, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Analytica Chimica Acta|January 1, 2018
Creasensor: SIMPLE technology for creatinine detection in plasmaFrancesco Dal Dosso, Deborah Decrop, Elena Pérez-Ruiz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Dermatological Treatment|October 6, 2020
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured surveyLisa Schots, Lynda Grine, Rani Soenen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 23, 2022
Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohortLisa Schots, Rani Soenen, Brigitte Blanquart, et al.
Dermatology and Therapy|October 4, 2024
Demographics, Disease Characteristics, and Time to Effective Treatment of Patients with Psoriasis in the Ghent PsoPlus Cohort of 2021Evelyn Meulewaeter, Anke Eylenbosch, Evelien Verhaeghe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2025
From reactive to predictive: Advancing biologic dosing in dermatologyAnke Eylenbosch, Ruoheng Wei, Rani Soenen, et al.
Clinical and Experimental Dermatology|March 4, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasisRani Soenen, Zhigang Wang, Lynda Grine, et al.
Journal of Clinical Medicine|June 10, 2022
Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical PracticeRani Soenen, Christophe Stove, Alessio Capobianco, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2020
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasisNathalie Van den Berghe, Aurélie Truffot, Miet Peeters, et al.
The Journal of Investigative Dermatology|July 8, 2026
Population Pharmacokinetic-Pharmacodynamic Model for Secukinumab in Psoriasis PatientsAnke Eylenbosch, Rani Soenen, Charlotte A M van Riel, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Analytica Chimica Acta|January 1, 2018
Creasensor: SIMPLE technology for creatinine detection in plasmaFrancesco Dal Dosso, Deborah Decrop, Elena Pérez-Ruiz, et al.
Pageof 2